FDA announces end to Wegovy and Ozempic drug shortages
Patients on semaglutide ( Ozempic, Wegovy) had a 32% increased relative risk of developing nonarteritic anterior ischemic ...
The Food and Drug Administration said Friday the shortage of Ozempic and Wegovy is over, a step that could spell the end to a booming market of cheap, pharmacy-made weight-loss drugs that has ...
Besides Mankind, Natco Pharma, Dr Reddy’s, Sun Pharma and others are already gearing up for launches of weight-loss drugs ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results